← Back to Search

Patient decision aid for Lung Cancer (SDM-LCS-SC Trial)

N/A
Waitlist Available
Led By Russell Glasgow, MD
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month follow-up
Awards & highlights

SDM-LCS-SC Trial Summary

This trialaims to help rural primary care practices follow lung cancer screening guidelines & provide smoking cessation services for better health outcomes.

Eligible Conditions
  • Lung Cancer
  • Smoking Cessation

SDM-LCS-SC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month follow up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month follow up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Count of participants who's health visit adhered to the LCS guidelines and CMS coverage criteria in rural primary care practices: baseline survey
Count of participants who's health visit adhered to the LCS guidelines and CMS coverage criteria in rural primary care practices: follow-up survey
Secondary outcome measures
Patient knowledge about lung cancer

SDM-LCS-SC Trial Design

2Treatment groups
Active Control
Group I: Patient decision aidActive Control1 Intervention
The intervention group will consist of each participant and clinic once they move to the intervention phase (stepped-wedge design: practices will be randomized into step 1, 2 or 3; for step 1: the intervention will start at 2 months, for step 2: the intervention will start at 4 months, for step 3: the intervention will start at 6 months).
Group II: ControlActive Control1 Intervention
The control group will consist of each participant and clinic before the intervention (baseline, first 2 months).

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,666 Previous Clinical Trials
40,925,887 Total Patients Enrolled
University of Colorado, DenverLead Sponsor
1,738 Previous Clinical Trials
2,149,408 Total Patients Enrolled
High Plains Research NetworkNETWORK
4 Previous Clinical Trials
6,907 Total Patients Enrolled

Media Library

Patient decision aid Clinical Trial Eligibility Overview. Trial Name: NCT04897568 — N/A
Lung Cancer Research Study Groups: Patient decision aid, Control
Lung Cancer Clinical Trial 2023: Patient decision aid Highlights & Side Effects. Trial Name: NCT04897568 — N/A
Patient decision aid 2023 Treatment Timeline for Medical Study. Trial Name: NCT04897568 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an age limit for recruitment in this investigation?

"This trial stipulates that only participants aged 50 and 80 are eligible. Of the total pool of applicants, 49 were minors while 1,750 were senior citizens."

Answered by AI

Are there any available positions in this clinical trial for participants?

"Clinicaltrials.gov reports that this medical experiment is not actively recruiting patients, despite having been first posted on July 15th 2020 and last updated October 10th 2022. However, there are still 1768 other clinical trials which are currently enrolling participants."

Answered by AI

Am I eligible to register for this research program?

"This research initiative is searching for 118 individuals aged between 50 and 80 who are either active smokers or have quit within the last 15 years. Furthermore, participants must be asymptomatic to lung cancer symptoms."

Answered by AI

Who else is applying?

What state do they live in?
Colorado
What site did they apply to?
University of Colorado Hospital
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0
~25 spots leftby Apr 2025